| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $357.9M | $328.1M | $269.1M |
| YoY Revenue Growth % | +9.1% | +21.9% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$23.2M | -$28.6M | $142.0K |
| Operating Margin % | -6.5% | -8.7% | 0.1% |
| Net Income (GAAP) | -$32.9M | $193.8M | $8.0M |
| EBITDA (Normalized) | $263.9M | $226.7M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $101.0M | $62.6M | $113.8M |
| Capital Expenditures (CapEx) | $358.9M | $319.1M | — |
| Free Cash Flow (FCF) | -$257.9M | -$256.5M | $113.8M |
| FCF Margin % | -72.1% | -78.2% | 42.3% |
| Return on Invested Capital (ROIC %) | -1.2% | -1.8% | — |
| Cash & Short-Term Equivalents | $27.3M | $46.3M | — |
| Total Debt (Short + Long Term) | $628.2M | $407.7M | — |
| Total Stockholders' Equity | $880.8M | $918.6M | — |